These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19165723)

  • 1. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn.
    Pan H; Chen K; Chu L; Kinderman F; Apostol I; Huang G
    Protein Sci; 2009 Feb; 18(2):424-33. PubMed ID: 19165723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidation.
    Gao X; Ji JA; Veeravalli K; Wang YJ; Zhang T; Mcgreevy W; Zheng K; Kelley RF; Laird MW; Liu J; Cromwell M
    J Pharm Sci; 2015 Feb; 104(2):368-77. PubMed ID: 25175600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.
    Wang W; Vlasak J; Li Y; Pristatsky P; Fang Y; Pittman T; Roman J; Wang Y; Prueksaritanont T; Ionescu R
    Mol Immunol; 2011 Mar; 48(6-7):860-6. PubMed ID: 21256596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
    Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
    MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.
    Gaza-Bulseco G; Faldu S; Hurkmans K; Chumsae C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):55-62. PubMed ID: 18567545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein aggregates on characterization of FcRn binding of Fc-fusion therapeutics.
    Bajardi-Taccioli A; Blum A; Xu C; Sosic Z; Bergelson S; Feschenko M
    Mol Immunol; 2015 Oct; 67(2 Pt B):616-24. PubMed ID: 26254986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
    Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
    J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments.
    Mi W; Wanjie S; Lo ST; Gan Z; Pickl-Herk B; Ober RJ; Ward ES
    J Immunol; 2008 Dec; 181(11):7550-61. PubMed ID: 19017944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1.
    Schuck P; Radu CG; Ward ES
    Mol Immunol; 1999; 36(15-16):1117-25. PubMed ID: 10698313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding structures and energies of the human neonatal Fc receptor with human Fc and its mutants by molecular modeling and dynamics simulations.
    Huang X; Zheng F; Zhan CG
    Mol Biosyst; 2013 Dec; 9(12):3047-58. PubMed ID: 24057047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Impact of Methionine Oxidation on the Biological Functions of IgG1 Antibodies Using Hydrogen/Deuterium Exchange Mass Spectrometry.
    Mo J; Yan Q; So CK; Soden T; Lewis MJ; Hu P
    Anal Chem; 2016 Oct; 88(19):9495-9502. PubMed ID: 27575380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
    Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
    Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.
    Stapleton NM; Brinkhaus M; Armour KL; Bentlage AEH; de Taeye SW; Temming AR; Mok JY; Brasser G; Maas M; van Esch WJE; Clark MR; Williamson LM; van der Schoot CE; Vidarsson G
    Sci Rep; 2019 May; 9(1):7363. PubMed ID: 31089170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors.
    Bertolotti-Ciarlet A; Wang W; Lownes R; Pristatsky P; Fang Y; McKelvey T; Li Y; Li Y; Drummond J; Prueksaritanont T; Vlasak J
    Mol Immunol; 2009 May; 46(8-9):1878-82. PubMed ID: 19269032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding.
    Martin WL; West AP; Gan L; Bjorkman PJ
    Mol Cell; 2001 Apr; 7(4):867-77. PubMed ID: 11336709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
    Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
    MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the complex of rat neonatal Fc receptor with Fc.
    Burmeister WP; Huber AH; Bjorkman PJ
    Nature; 1994 Nov; 372(6504):379-83. PubMed ID: 7969498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.